GNFT - GENFIT - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

140M

Cash

140.6M

Avg Qtr Burn

-18.16M

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

4.33%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Elafibranor Details Primary biliary cholangitis, Liver disease Big Mover™ Suspected Mover™ Susp. Mover™	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nitazoxanide Details Acute-on-Chronic liver failure, Liver disease	Phase 2a Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Elafibranor Details Non-alcoholic steatohepatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.